It is currently Tue Feb 09, 2016 6:04 am

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

milestones....

Our 24th wedding anniversary June 9th. From college newlyweds to adults.

I'm proud of us. This last year has been the most challenging yet.

thanks for letting me share it with y'all-
AC
Read more : milestones.... | Views : 1522 | Replies : 4 | Forum : Daily Life


Sonic hedgehoc, (No really!),wakes up stem cells

I'm not sure if this has been covered elsewhere, but I find this story remarkably encouraging: the whole concept of triggering our brains' own repair mechanisms overcomes so many of the hurdles facing other therapies that it sounds like a dream come true…
Public release date: 6-Jun-2008


Contact: Patti Jacobs
pjacobs12@comcast.net
617-864-2712
Schepens Eye ...
Read more : Sonic hedgehoc, (No really!),wakes up stem cells | Views : 1605 | Replies : 8 | Forum : General Discussion


Copaxone--Mechanism of Neuroprotection

Hi again

This is old news but I thought I'd post it anyway.

T cell independent mechanism for copolymer-1-induced neuroprotection
Despite active investigation of copolymer-1 (Cop-1) for nearly 40 years the mechanisms underlying its neuroprotective properties remain contentious. Nonetheless, current dogma for Cop-1 neuroprotective activities in autoimmune and neurodegenerative diseases include bystander suppression of autoimmune T cells and attenuation of microglial responses. In this report, we demonstrate that Cop-1 interacts directly with primary human ...
Read more : Copaxone--Mechanism of Neuroprotection | Views : 1576 | Replies : 0 | Forum : Copaxone


Type I interferon target revealed

Nature Reviews Immunology 8, 402 (June 2008) | doi:10.1038/nri2339

Sarah Allan
AutoimmunityType I interferon target revealed

Treatment with interferon-beta (IFNbeta) reduces disease exacerbation in many patients with multiple sclerosis, but how this cytokine inhibits autoimmune inflammation in the central nervous system (CNS) is largely unknown. Now, Prinz, Kalinke and colleagues have revealed that the effect of type I IFNs on myeloid cells is crucial to the protective effect of this cytokine in the relevant animal ...
Read more : Type I interferon target revealed | Views : 1183 | Replies : 0 | Forum : Drug Pipeline


Pilot Study: Naturopathic Medicine for MS

Hi all

Here's a link to an article (pdf) that may be of interest to some.
A Randomized Pilot Study of Naturopathic Medicine in Multiple Sclerosis

Conclusions: Naturopathic medicine combined with usual care for MS showed a trend in improvement in the General Health subscale of the SF-36, Timed Walk, and neurologic impairment. Evaluation of naturopathic medicine, as a multimodality regimen, warrants further investigation.

Now if we could just convince them to add normal ...
Read more : Pilot Study: Naturopathic Medicine for MS | Views : 1632 | Replies : 1 | Forum : Natural Approach


How do you tell your co-workers? Or do you?

Hello, I am new here. Diagnoised Feb, 07. Definately not enjoying this monster. I have went from extremely active to having a hard time walking. I am really struggling with telling people about this disease. I work with mostly men and I dont want them to treat me like I am sick, however it is becoming noticeable. Does any one have advise?
Read more : How do you tell your co-workers? Or do you? | Views : 3938 | Replies : 31 | Forum : General Discussion


Novartis says FTY720 trial continues despite death

Novartis says FTY720 trial continues despite death

By Sam Cage

ZURICH, June 5 (Reuters) - Novartis AG (NOVN.VX: Quote, Profile, Research) said two patients taking its multiple sclerosis drug FTY720 in clinical trials had problems with infections and one died, but the role of the medicine in the cases was unclear.

Independent experts recommended that clinical trials with the drug -- which unusually for an MS medicine is taken orally -- should continue as planned, ...
Read more : Novartis says FTY720 trial continues despite death | Views : 2319 | Replies : 1 | Forum : Drug Pipeline


Concussion / brain injury update

Well it has been about a month and a half since I took a header off the stairs and ended up in the ER with a brain injury / concussion. Time for an update. Most of the major headaches and vertigo have calmed down. What I have left is serious equilibrium / balance problems and I have not regained my sense of smell. My ON seems to be worse now as well. Prognosis is unknown ...
Read more : Concussion / brain injury update | Views : 1255 | Replies : 3 | Forum : General Discussion


i'm back (just a warning to you all)...

hey everyone hope this finds everyone doing okay out there...its been awhile since i have been on here..been working thru some things so havent been on..could have used the support but when you can get to the computer what can i do..anyways update...i have had problems with my right side even more now and have another mri scheduled for next week..yippy there..have a problem with dizziness to the point layed me out at work to ...
Read more : i'm back (just a warning to you all)... | Views : 1688 | Replies : 10 | Forum : General Discussion


Resveratrol in the news

From the NY Times...

Sirtris, a start up biochemical co. trying to patent drugs based on red wines' resveratrol, was purchased by GlaxoSmithKline for 720 million. You know when drug companies are trying to patent and replicate natural substances, that there's something there that works.


"Serious scientists have long derided the idea of life-extending elixirs, but the door has now been opened to drugs that exploit an ancient biological survival mechanism, that of switching the ...
Read more : Resveratrol in the news | Views : 1785 | Replies : 1 | Forum : Natural Approach


 

Login  •  Register


Statistics

Total posts 230317 • Total topics 24457 • Total members 15700


Contact us | Terms of Service